Pyoderma gangrenosum associated with sarcoidosis [14]

Acta Dermato-Venereologica

Volumn 83, Issue 2, 2003, Pages 153-154

  Kontochristopoulos, G ^a   Saxioni, E ^a   Doulaveri Gherasim, G ^a   Politis, G ^b   Zakopoulou, N ^a  

^a A Syngros Hospital   (Greece)

^b Hospital for Diseases of the Chest SOTIRIA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; DIPEPTIDYL CARBOXYPEPTIDASE; PREDNISOLONE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; ENZYME BLOOD LEVEL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RELAPSE; SARCOIDOSIS; SKIN BIOPSY; STEROID THERAPY; THORAX RADIOGRAPHY;

ANTI-INFLAMMATORY AGENTS; BIOPSY; COLCHICINE; DRUG THERAPY, COMBINATION; GOUT SUPPRESSANTS; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; PYODERMA GANGRENOSUM; SARCOIDOSIS; SKIN; TREATMENT OUTCOME; WOUND HEALING;

EID: 0037261646     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310007625     Document Type: Letter

References (10)

1. Powell FC, Su WPD, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.
2. Wolff K, Stingl G. Pyoderma gangrenosum. In: Freedberg IM, Eisen AJ, Wolff K, eds. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1999: 1140-1148.
3. Losala A, Garcia-Doval I, De la Torre C, Cruises MJ. Subcutaneous sarcoidosis worsened by cyclosporine treatment for pyoderma gangrenosum. Br J Dermatol 1998; 138: 1103-1104.
4. Powell FC, Schroeter AL, Su WPD, Perry HO. Pyoderma gangrenosum and sarcoidosis. Arch Dermatol 1984; 120: 959-960.
5. English JC, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol 2001; 44: 725-743.
6. Mizuki M, Eklund A, Grunewald J. Altered expression of natural killer cell inhibitory receptors (KIRs) on cells in bronchoaveolar lavage fluid and peripheral blood of sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 54-59.
7. Dai H, Guzman J, Costabel U. Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis. Eur Respir J 1999; 13: 1451-1454.
8. Rampal P, Benzaken S, Schneider S, Hebuterne X. Colchicine in pyoderma gangrenosum. Lancet 1998; 351: 1134-1135.
9. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28: 48-59.
10. Sullivan TP, King LE, Boyd AS. Colchicine in dermatology. J Am Acad Dermatol 1998; 39: 993-999.